TIAA CREF INVESTMENT MANAGEMENT LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 166 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$5,601,000
+99.2%
413,951
+52.5%
0.00%
+100.0%
Q4 2018$2,812,000
-72.7%
271,386
-51.3%
0.00%
-33.3%
Q3 2018$10,284,000
+76.0%
557,104
+82.3%
0.00%
-25.0%
Q2 2018$5,844,000
-6.7%
305,643
-24.7%
0.00%0.0%
Q1 2018$6,262,000
+26.8%
405,827
+23.2%
0.00%
+33.3%
Q4 2017$4,938,000
-10.7%
329,399
-6.1%
0.00%
-25.0%
Q3 2017$5,532,000
-19.0%
350,782
-3.1%
0.00%
-20.0%
Q2 2017$6,832,000
+13.7%
361,859
+2.7%
0.01%
+25.0%
Q1 2017$6,009,000
+6.1%
352,255
-4.9%
0.00%0.0%
Q4 2016$5,663,000
-9.5%
370,378
-6.0%
0.00%0.0%
Q3 2016$6,259,000
+19.9%
394,140
-1.3%
0.00%0.0%
Q2 2016$5,221,000
+18.9%
399,290
-0.5%
0.00%
+33.3%
Q1 2016$4,392,000
-6.9%
401,483
-1.4%
0.00%
-25.0%
Q4 2015$4,719,000
+9.8%
407,149
-1.3%
0.00%
+33.3%
Q3 2015$4,297,000
-19.4%
412,385
-6.7%
0.00%
-25.0%
Q2 2015$5,330,000
-21.8%
441,935
+3.7%
0.00%
-20.0%
Q1 2015$6,816,000
+1.8%
426,023
-2.5%
0.01%0.0%
Q4 2014$6,693,000
+12.1%
436,893
-5.2%
0.01%
+25.0%
Q3 2014$5,973,000
-16.9%
461,084
-1.7%
0.00%
-20.0%
Q2 2014$7,191,000
+42.3%
469,077
+14.4%
0.01%
+25.0%
Q1 2014$5,052,000
+12.3%
410,061
+5.9%
0.00%
+33.3%
Q4 2013$4,497,000
+1.4%
387,331
+3.5%
0.00%0.0%
Q3 2013$4,433,000
+15.1%
374,087
-3.4%
0.00%0.0%
Q2 2013$3,851,000387,0730.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,855,515$43,661,00013.90%
BLUE JAY CAPITAL MANAGEMENT, LLC 772,369$11,810,0007.13%
Rubric Capital Management LP 1,275,000$19,495,0006.70%
SECTOR GAMMA AS 1,972,678$30,162,0005.68%
BRIDGER MANAGEMENT, LLC 1,879,313$28,735,0002.00%
Asymmetry Capital Management, L.P. 57,363$877,0001.63%
Orbimed Advisors 7,241,300$110,719,0001.41%
Broderick Brian C 144,476$2,209,0000.96%
Granahan Investment Management 1,408,000$21,528,0000.74%
Spark Investment Management LLC 499,200$7,632,0000.63%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders